Valuation & Multiples

How do PE firms value medical practices?

Private equity (PE) is investment capital from funds that buy controlling stakes in companies, hold them 3 to 7 years, and sell to the next buyer at a higher value.

Reviewed by Stanislav Sukhinin, CFALast reviewed April 12, 2026

Quick answer

Private equity firms value medical practices primarily on a multiple of trailing twelve-month adjusted EBITDA, typically 5x to 12x, with the multiple driven by scale, growth, payer mix, and provider retention.

The detail

PE valuation of a medical practice happens in three steps. First, normalize EBITDA by adding back owner above-market compensation, personal expenses, one-time items, and pro forma adjustments for new providers and locations. Second, apply a multiple based on practice size: under $1M EBITDA trades at 4x to 6x, $1M to $3M EBITDA trades at 6x to 9x, $3M to $10M trades at 8x to 12x, and platform-scale assets ($10M+) trade at 10x to 16x. Third, structure consideration: typical PE deals pay 60 to 80 percent in cash at close, 10 to 20 percent in rollover equity, and 5 to 20 percent in earnouts contingent on retained EBITDA over 12 to 36 months. Rollover equity is the most important provision to negotiate because it determines your second bite at the next exit, which is typically 2 to 4x the value of the first.

What this means for clinic owners

From Sorso

The first PE offer you receive is rarely the best one. Multiples vary by 30 to 50 percent across competing buyers for the same practice. If you take an unsolicited offer without running a process, you almost certainly leave money on the table.

SS
Stanislav Sukhinin, CFA

Founder of Sorso. 19 years in corporate finance. Managed a $450M loan portfolio before building a fractional CFO firm exclusively for healthcare clinics.

Want to see how your practice measures up?

Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.